Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Karuna Therapeutics Q4 EPS $(3.01) Misses $(2.65) Estimate

Author: Benzinga Newsdesk | February 22, 2024 07:33am
Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(3.01) per share which missed the analyst consensus estimate of $(2.65) by 13.58 percent. This is a 35.59 percent decrease over losses of $(2.22) per share from the same period last year.

Posted In: KRTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist